APRE Reverse Stock Split: My Take on the 8-K

$APRE Aprea Therapeutics, Inc. (APRE) — 8-K
⚠️ Not financial advice. For educational purposes only.

Aprea Therapeutics (APRE) held its annual shareholder meeting and key decisions were made regarding director elections and auditor ratification. The most significant outcome is the approval of a potential reverse stock split, which could impact all investors.

🔗 Full filing on SEC.gov: https://www.sec.gov/Archives/edgar/data/1781983/000110465926075151/0001104659-26-075151-index.htm

⏱️ Timestamps:
0:00 - Introduction
0:27 - $APRE 8-K Filing Overview
0:33 - $APRE Shareholder Meeting Details
0:38 - $APRE Director Election Results
0:42 - $APRE Broker Non-Votes Explained
0:48 - $APRE Auditor Ratification
1:24 - $APRE EisnerAmper LLP Approval
1:47 - $APRE Certificate of Incorporation Amendment
3:01 - $APRE Reverse Stock Split Proposal
3:22 - $APRE Reverse Stock Split Rationale
3:41 - $APRE Impact on Investors
💬 Join our Discord: https://discord.gg/Dv9DTGayGH

#APRE #Aprea #8K #SEC #investing #stockanalysis #smallcap #SECfiling

---
DISCLAIMER: This video is AI-generated analysis of publicly available SEC filings. It is for educational and informational purposes only and is NOT financial, investment, legal, or tax advice. No content here should be construed as a recommendation to buy, sell, or hold any security. Always consult a licensed financial advisor before making investment decisions.

Corporate Decoder makes SEC filings accessible to everyone.

Видео APRE Reverse Stock Split: My Take on the 8-K канала Corporate Decoder